Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study

• Үндсэн зохиолчид: Kyriakos Souliotis (Зохиогч), Eirini Agapidaki (Зохиогч), Manto Papageorgiou (Зохиогч), Niki Voudouri (Зохиогч), Xenophon Contiades (Зохиогч)
• Формат: Ном
• Хэвлэсэн: BMC, 2017-06-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Abstract Background Evidence suggests that Greece is among the European countries with increased trend in HCV prevalence among injecting drug users (IDUs) from 2008 to 2014. Nonetheless, the access of IDUs to treatment for Hepatitis C Virus (HCV) is very limited while the risk of co-infection and tr...